Cargando…

421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest

BACKGROUND: Babesiosis is a tick-borne illness caused by protozoal infection of the genus Babesia. Clinical presentation varies widely from asymptomatic to rapidly fatal infection and diagnosis requires a high index of clinical suspicion. It is an emerging health risk and clinicians need to be aware...

Descripción completa

Detalles Bibliográficos
Autores principales: Fida, Madiha, Hamdi, Ahmed, Saleh, Omar Abu, O’Horo, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255292/
http://dx.doi.org/10.1093/ofid/ofy210.432
_version_ 1783373905924194304
author Fida, Madiha
Hamdi, Ahmed
Saleh, Omar Abu
O’Horo, John
author_facet Fida, Madiha
Hamdi, Ahmed
Saleh, Omar Abu
O’Horo, John
author_sort Fida, Madiha
collection PubMed
description BACKGROUND: Babesiosis is a tick-borne illness caused by protozoal infection of the genus Babesia. Clinical presentation varies widely from asymptomatic to rapidly fatal infection and diagnosis requires a high index of clinical suspicion. It is an emerging health risk and clinicians need to be aware of its different clinical manifestations. METHODS: We retrospectively collected and analyzed data from 38 patients with babesiosis from 1990 to 2015. RESULTS: Mean age of patients was 63 years. 68% of patients required hospitalization with 21% requiring intensive care unit (ICU) stay. Mean length of illness before diagnosis was 15.6 days and symptoms comprised of malaise (82%), subjective fever (71%), chills (55%), anorexia (29%), arthralgia (29%), and nausea (16%). Only 47% of the patients recalled tick bites. Mean hemoglobin in the outpatients was 12.4 g/dL compared with 9.8 g/dL in the hospitalized patients (P < 0.01). Among hospitalized patients, mean hemoglobin for ICU admissions was 7.5 g/dL vs. 10.9 g/dL (P < 0.01) for those without ICU stay. Mean parasitemia was 10.1% in those requiring ICU compared with 1.4% in those admitted to the medical floor (P < 0.01). 28.9% had Lyme disease, and 10.5% had anaplasma coinfection. Co-morbidities included diabetes mellitus (n = 3), asplenia (n = 5), and immunosuppression (n = 3). Diagnosis was made with PCR and peripheral smear in 50% of patient whereas 50% were diagnosed with PCR alone. In 27% of patients with positive PCR, peripheral smear was negative. All patients with asplenia required hospitalization with 3/5 requiring ICU with initial parasitemia ranging from 2.5 to 28% and duration of parasitemia ranging from 10 to 142 days. Initial treatment comprised of clindamycin plus quinine in 31% of patients whereas combination of atovaquone and azithromycin was used in 69% of patients. Median duration of treatment was 10 days. Overall three patients underwent exchange transfusion with parasitemias ranging from 12.3 to 28.5%. None of the patients died during hospitalization. CONCLUSION: Less than half of the patients with babesiosis recall tick bites. There is usually a delay in diagnosis of up to 2 weeks due to nonspecific nature of symptoms. In more than one-fourth of patients with babesiosis peripheral smear may be falsely negative. Hemoglobin and percentage parasitemia seemed to correlate with severity of illness. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6255292
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62552922018-11-28 421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest Fida, Madiha Hamdi, Ahmed Saleh, Omar Abu O’Horo, John Open Forum Infect Dis Abstracts BACKGROUND: Babesiosis is a tick-borne illness caused by protozoal infection of the genus Babesia. Clinical presentation varies widely from asymptomatic to rapidly fatal infection and diagnosis requires a high index of clinical suspicion. It is an emerging health risk and clinicians need to be aware of its different clinical manifestations. METHODS: We retrospectively collected and analyzed data from 38 patients with babesiosis from 1990 to 2015. RESULTS: Mean age of patients was 63 years. 68% of patients required hospitalization with 21% requiring intensive care unit (ICU) stay. Mean length of illness before diagnosis was 15.6 days and symptoms comprised of malaise (82%), subjective fever (71%), chills (55%), anorexia (29%), arthralgia (29%), and nausea (16%). Only 47% of the patients recalled tick bites. Mean hemoglobin in the outpatients was 12.4 g/dL compared with 9.8 g/dL in the hospitalized patients (P < 0.01). Among hospitalized patients, mean hemoglobin for ICU admissions was 7.5 g/dL vs. 10.9 g/dL (P < 0.01) for those without ICU stay. Mean parasitemia was 10.1% in those requiring ICU compared with 1.4% in those admitted to the medical floor (P < 0.01). 28.9% had Lyme disease, and 10.5% had anaplasma coinfection. Co-morbidities included diabetes mellitus (n = 3), asplenia (n = 5), and immunosuppression (n = 3). Diagnosis was made with PCR and peripheral smear in 50% of patient whereas 50% were diagnosed with PCR alone. In 27% of patients with positive PCR, peripheral smear was negative. All patients with asplenia required hospitalization with 3/5 requiring ICU with initial parasitemia ranging from 2.5 to 28% and duration of parasitemia ranging from 10 to 142 days. Initial treatment comprised of clindamycin plus quinine in 31% of patients whereas combination of atovaquone and azithromycin was used in 69% of patients. Median duration of treatment was 10 days. Overall three patients underwent exchange transfusion with parasitemias ranging from 12.3 to 28.5%. None of the patients died during hospitalization. CONCLUSION: Less than half of the patients with babesiosis recall tick bites. There is usually a delay in diagnosis of up to 2 weeks due to nonspecific nature of symptoms. In more than one-fourth of patients with babesiosis peripheral smear may be falsely negative. Hemoglobin and percentage parasitemia seemed to correlate with severity of illness. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6255292/ http://dx.doi.org/10.1093/ofid/ofy210.432 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Fida, Madiha
Hamdi, Ahmed
Saleh, Omar Abu
O’Horo, John
421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest
title 421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest
title_full 421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest
title_fullStr 421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest
title_full_unstemmed 421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest
title_short 421. Babesiosis: Retrospective Review of 38 Cases from Upper Midwest
title_sort 421. babesiosis: retrospective review of 38 cases from upper midwest
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255292/
http://dx.doi.org/10.1093/ofid/ofy210.432
work_keys_str_mv AT fidamadiha 421babesiosisretrospectivereviewof38casesfromuppermidwest
AT hamdiahmed 421babesiosisretrospectivereviewof38casesfromuppermidwest
AT salehomarabu 421babesiosisretrospectivereviewof38casesfromuppermidwest
AT ohorojohn 421babesiosisretrospectivereviewof38casesfromuppermidwest